Stockscreener 앱 받기
42.72
0.79%
0.335
시간 외 거래:
42.15
-0.565
-1.32%
전일 마감가:
$42.38
열려 있는:
$43.32
하루 거래량:
30,483
Relative Volume:
2.88
시가총액:
$168.21M
수익:
$17,000
순이익/손실:
$-23.87M
주가수익비율:
-13.69
EPS:
-3.12
순현금흐름:
$-22.03M
1주 성능:
+9.58%
1개월 성능:
+56.18%
6개월 성능:
+183.44%
1년 성능:
+190.14%
1일 변동 폭
$40.77
$44.00
1주일 범위
$38.22
$44.00
52주 변동 폭
$13.20
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
명칭
Vtv Therapeutics Inc
전화
336-841-0300
주소
3980 PREMIER DR, HIGH POINT, NC
VTVT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
42.72 | 166.89M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 개시 | TD Cowen | Buy |
| 2025-11-19 | 개시 | BTIG Research | Buy |
| 2019-05-30 | 개시 | H.C. Wainwright | Buy |
| 2018-04-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-08 | 개시 | ROTH Capital | Buy |
| 2018-02-08 | 개시 | Northland Capital | Outperform |
| 2016-09-26 | 개시 | H.C. Wainwright | Buy |
| 2015-09-04 | 개시 | Canaccord Genuity | Buy |
| 2015-08-24 | 개시 | Piper Jaffray | Overweight |
| 2015-08-24 | 개시 | Stifel | Buy |
모두보기
Vtv Therapeutics Inc 주식(VTVT)의 최신 뉴스
Is vTv Therapeutics Inc. stock supported by innovation pipeline2026 world cup usa national team group stage goalkeepers build up play knockout prediction statistical analysis - Улправда
TD Cowen Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? - Yahoo Finance
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
VTVT: TD Cowen Initiates Coverage with a Buy Rating and $67 Pric - GuruFocus
vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at TD Cowen - MarketBeat
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
vTv Therapeutics stock initiated with Buy rating at TD Cowen By Investing.com - Investing.com Canada
How Vtv Therapeutics Inc. (VTVT) Affects Rotational Strategy Timing - Stock Traders Daily
Will vTv Therapeutics Inc. (5VT0) stock test record highs in 2025Bullish Engulfing Patterns & Outstanding Growth Opportunities - bollywoodhelpline.com
vTv Therapeutics (NASDAQ:VTVT) Upgraded at Wall Street Zen - MarketBeat
Discipline and Rules-Based Execution in VTVT Response - Stock Traders Daily
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
vTv Therapeutics stock price target raised to $47 from $36 at H.C. Wainwright - Investing.com Canada
How vTv Therapeutics Inc. stock reacts to global recession fearsJuly 2025 Highlights & Weekly Stock Breakout Alerts - Улправда
Can vTv Therapeutics Inc. stock double in next 5 yearsJuly 2025 Levels & Real-Time Market Trend Scan - Улправда
Will vTv Therapeutics Inc. (5VT0) stock announce special dividend2025 Pullback Review & Free Technical Pattern Based Buy Signals - Улправда
How vTv Therapeutics Inc. stock performs in interest rate cyclesWeekly Market Report & Consistent Income Trade Ideas - Улправда
What technical charts say about vTv Therapeutics Inc. stock2025 Price Action Summary & Low Drawdown Momentum Ideas - Улправда
EV Market: How vTv Therapeutics Inc. stock valuations compare to rivals2025 Technical Overview & Consistent Income Trade Recommendations - moha.gov.vn
HC Wainwright & Co. Raises Price Target for VTVT to $47 | VTVT S - GuruFocus
HC Wainwright & Co. Maintains vTv Therapeutics (VTVT) Buy Recommendation - Nasdaq
Is vTv Therapeutics Inc. stock recession proof2025 AllTime Highs & Low Risk High Win Rate Picks - DonanımHaber
We're Interested To See How vTv Therapeutics (NASDAQ:VTVT) Uses Its Cash Hoard To Grow - Yahoo Finance
Why vTv Therapeutics Inc. (5VT0) stock appeals to dividend investorsJuly 2025 Update & Fast Momentum Stock Entry Tips - DonanımHaber
Aug Sentiment: What hedge fund activity signals for vTv Therapeutics Inc stock2025 Support & Resistance & Technical Pattern Based Signals - moha.gov.vn
Rally Mode: How vTv Therapeutics Inc. stock reacts to global recession fearsTrade Exit Report & Weekly Breakout Stock Alerts - Улправда
vTv Therapeutics submits protocol for phase 2 diabetes drug trial By Investing.com - Investing.com South Africa
VTVT FinancialsIncome Statement - Quiver Quantitative
vTv Therapeutics submits protocol for phase 2 diabetes drug trial - Investing.com India
vTv Therapeutics Announces Phase 2 Clinical Study for Cadisegliatin in Type 2 Diabetes in Collaboration with M42’s IROS - Quiver Quantitative
vTv Therapeutics and M42’s IROS Announce Submission of - GlobeNewswire
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - Sahm
Will vTv Therapeutics Inc. (5VT0) stock hit Wall Street targets2025 Trading Volume Trends & Reliable Price Breakout Signals - Улправда
vTv Therapeutics Earnings Notes - Trefis
Investment Report: Is vTv Therapeutics Inc stock oversold or undervaluedJuly 2025 Short Interest & Low Drawdown Trading Techniques - moha.gov.vn
(VTVT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
vTv Therapeutics’ Promising Phase 3 Study on Cadisegliatin for Type 1 Diabetes - MSN
Alzheimer’s Disease Market in the 7MM is USD 5,048 million in 2025, analyses DelveInsight - The Globe and Mail
Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect? - MSN
Big Money Moves: Why vTv Therapeutics Inc stock remains a top recommendation - moha.gov.vn
vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above Fifty Day Moving AverageHere's What Happened - MarketBeat
Why vTv Therapeutics Inc. stock remains a top recommendationM&A Rumor & High Accuracy Swing Trade Signals - Newser
What makes vTv Therapeutics Inc. (5VT0) stock appealing to growth investorsWeekly Profit Summary & Consistent Income Trade Ideas - Newser
How vTv Therapeutics Inc. (5VT0) stock moves in volatile trading sessionsJuly 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - Newser
Can vTv Therapeutics Inc. (5VT0) stock hit consensus price targetsMarket Risk Analysis & Long-Term Safe Investment Ideas - Newser
Why vTv Therapeutics Inc. stock is a must watch in 20252025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Is vTv Therapeutics Inc. stock resilient to inflationSell Signal & Stock Market Timing Techniques - Newser
Analysts Are Bullish on Top Healthcare Stocks: vTv Therapeutics (VTVT), Theravance Biopharma (TBPH) - The Globe and Mail
How dovish Fed policy supports vTv Therapeutics Inc. (5VT0) stockTrade Ideas & Free Verified High Yield Trade Plans - Newser
Vtv Therapeutics Inc (VTVT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):